Gabelli Funds’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-330,423
Closed -$8.93M 1123
2024
Q2
$8.93M Buy
330,423
+255,031
+338% +$5.3M 0.07% 324
2024
Q1
$1.38M Hold
75,392
0.01% 727
2023
Q4
$925K Sell
75,392
-23,608
-24% -$221K 0.01% 806
2023
Q3
$1.48M Buy
99,000
+52,997
+115% +$1.1M 0.01% 719
2023
Q2
$1.49M Buy
46,003
+1,003
+2% +$36.6K 0.01% 719
2023
Q1
$1.76M Buy
45,000
+35,000
+350% +$1.71M 0.01% 684
2022
Q4
$529K Sell
10,000
-14,800
-60% -$721K ﹤0.01% 927
2022
Q3
$1.12M Hold
24,800
0.01% 794
2022
Q2
$902K Hold
24,800
0.01% 878
2022
Q1
$1.02M Sell
24,800
-5,000
-17% -$176K 0.01% 881
2021
Q4
$1.27M Sell
29,800
-44,000
-60% -$2.2M 0.01% 839
2021
Q3
$4.06M Buy
73,800
+4,800
+7% +$251K 0.03% 563
2021
Q2
$3.3M Buy
69,000
+5,000
+8% +$255K 0.02% 625
2021
Q1
$3.24M Buy
+64,000
New +$3.56M 0.02% 620

Other funds holding SILK

Gabelli Funds's SILK Position: Q3 2024 in Review

Gabelli Funds sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 330,423 shares — an estimated $8.93M sold.

Gabelli Funds first reported a position in SILK in Q1 2021 and held it in 14 quarters. The position peaked at $8.93M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Gabelli Funds reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Gabelli Funds sold 330,423 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $8.93M.
  • Gabelli Funds first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2021 and held it in 14 quarters.
  • Gabelli Funds's Silk Road Medical, Inc. Common Stock position peaked at $8.93M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Gabelli Funds's 13F filing for Q3 2024, filed 13 Nov 2024.